Positron Corporation
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Positron Corporation Positron Corporation (POSC) develops, manufactures, and sells state-of-the-art positron emission tomography (PET) and PET-CT molecular imaging systems focused primarily on cardiac diagnostics, along with related clinical services and support solutions; its core products include the Attrius cardiac PET system, which features software for coronary artery overlay display, motion correction, and customizable protocols; the NeuSight PET-CT 64-slice scanner, offering advanced imaging for cardiology practices with reduced scan times and higher diagnostic accuracy compared to SPECT; PosiRx, an automated system for radiopharmaceutical preparation and delivery; and the forthcoming Affinity-CT4D 64-slice system targeting both cardiac and oncology imaging markets. The company provides turnkey solutions encompassing equipment acquisition, installation, staff training, isotope supply, and customer care plans like PosiStar, serving nuclear cardiologists, private practices, and healthcare providers seeking gold-standard cardiac disease detection and improved patient outcomes. Founded in 1983 and headquartered in Niagara Falls, New York, Positron operates principally in the United States, with technology co-development through its partnership with Shenyang Intelligent Nuclear Technology Co., a Neusoft Medical Systems subsidiary. In recent developments, Positron established a new corporate headquarters in the Niagara Falls area under a long-term lease in August 2025 to support growth, product showcase, and operational expansion; redomiciled from Texas to Delaware to enhance governance ahead of filing a Form 10 for SEC fully reporting status in November 2025; secured $8 million in funding for market expansion; entered an industry partnership with MedAxiom in October 2025; signed an OEM supply and distribution agreement for the NeuSight PET-CT; and partnered with Upbeat Cardiology Solutions in November 2024 to broaden access to PET-CT systems via leasing, purchasing, and comprehensive support services for cardiology practices nationwide.
Head-To-Head Review: Positron (OTCMKTS:POSC) versus Pressure BioSciences (OTCMKTS:PBIO)
Contrasting Positron (OTCMKTS:POSC) and AngioDynamics (NASDAQ:ANGO)
Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices
Reviewing Positron (OTCMKTS:POSC) and Tenon Medical (NASDAQ:TNON)
OPKO Health (NASDAQ:OPK) & Positron (OTCMKTS:POSC) Head-To-Head Review
Positron Corporation Announces Its Transition to a Reporting SEC Company
Positron Corporation Enters Industry Partnership Agreement with MedAxiom
Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network's Excellence Awards 2025
Positron Corporation Announces New Corporate Headquarters and Strategic Redomiciling to Delaware
Positron Corporation Secures Multi-Unit Sale of PET-CT Scanners to Leading Cardiology Group
Positron (OTCMKTS:POSC) Shares Up 0.2% – Still a Buy?
Positron Corporation Expands Market Presence with Sale of NeuSight PET-CT Scanner
Positron Corporation Secures Agreement to Sell Four PET-CT Scanners
Positron Corporation Secures $8 Million in Capital to Accelerate Growth and Market Expansion
Positron Corporation Secures Agreement for Three NeuSight PET-CT 64 Slice Scanners
AI chip startup Positron raises $23.5 million seed round to take on Nvidia
AI Hardware Industry Veteran Mitesh Agrawal Joins Positron as CEO—A Startup Aiming to Challenge Nvidia's Grip on AI Infrastructure
Positron Corporation Announces Sale of Attrius PET and NeuSight PET-CT Scanners
Positron Corporation Secures Agreement to Sell and Rent Eight NeuSight PET-CT Scanners
Actineer Appoints Radiopharmaceutical Executive Joseph Oliverio as President and CEO